Frequently Asked Questions:
The market for Pharmacogenomics is expected to reach US$ XX Bn in 2024.
The Pharmacogenomics market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2016-2024.
The base year of this report is 2015.
Abbott Laboratories, Inc., Affymetrix, Inc., AstraZeneca plc, Assurex Health, Bayer AG, GeneDX, F. Hoffmann-La Roche Ltd., Illumina, Inc, Myriad Genetics, Inc, Merck & Co, GE Healthcare are some of the major players in the global market.